CLYR Health Tirzepatide Review: Starter Prices & Terms (2026)

CLYR Health advertises compounded tirzepatide with vitamin B6, with a $149 starter month and separately priced packages for people already taking a GLP-1. Its named product page says each order is billed once, with medication, provider consultation, syringes and cold-chain shipping included. Those details matter more than treating its introductory price as an ongoing, every-dose rate.³

The main reservation is contractual: the product promises a full refund if treatment is inappropriate, while the general Terms say an initial order cannot be canceled after submission for clinical review and all fees are nonrefundable. Get the policy for your specific purchase clarified before paying.^3,4

What the packages cost

The $149 starter is labeled one month at the starting dose. A $269 package combines the first two months in one box; it is not $269 per month. Both are advertised as one-time purchases. Whether to advance treatment remains a clinical decision, rather than something a package purchase guarantees.³

For existing users, one-month packages are listed at $249, $299 and $329, corresponding to the displayed 5 mg, 10 mg and 12.5 mg choices. Two-month packages are $449, $499 and $499 respectively. These are product labels for comparing cost and supply, not instructions to choose or change a dose. Your provider must approve the treatment and regimen.³

The published packages include the consultation, medication, syringes and temperature-controlled shipping. The Terms also contain general language about taxes and possible shipping or handling charges. Confirm the complete amount due and whether any separately scheduled service is being added. The product's stated package inclusions do not establish a universal price for every CLYR service.^3,4

What the care and pharmacy disclosures establish

The Terms identify Clyr Health, LLC as a technology platform, with independent clinicians and pharmacies. They name MD Integrations as the medical network and The Pharmacy Hub as a pharmacy partner. These are disclosed relationships, not a guarantee of your assigned clinician or dispensing facility. The Terms also limit availability by state and treatment.⁴

The product page attributes preparation to a state-licensed 503A pharmacy and displays a LegitScript certification claim. Neither statement makes the compounded finished preparation FDA-approved. Certification and clinician biographies should not be treated as proof of a particular prescription's suitability or results. See our explanation of compounded tirzepatide's legal status.³

Reordering, cancellation and refunds

The named tirzepatide page says the full selected supply ships in one box and nothing renews automatically. You decide whether to reorder. The general Terms separately address certain subscriptions: recurring intervals appear at checkout, renewals or shipments can occur slightly early, and cancellation must be requested at least 48 hours before renewal, taking effect at period-end. Do not assume that general subscription clause changes a clearly documented one-time order, or that every other service follows the tirzepatide page.^3,4

More significantly, the product's full-ineligibility-refund promise conflicts with the Terms' initial-review cancellation prohibition and blanket nonrefund clause. A clinical denial and a voluntary change of mind are different events, but the broad legal wording does not clearly carve out the advertised denial protection. Ask CLYR to confirm that exception in writing. Partially used subscription periods are generally nonrefundable; appointments canceled with less than 24 hours' notice can incur a $25 no-show fee.⁴

The product estimates cold-pack delivery within one to three business days of provider approval; this is not a guaranteed arrival date. Check storage and handling instructions with the actual dispensing pharmacy. Discuss Zepbound side effects, gallbladder risk and the thyroid cancer warning with your clinician rather than relying on testimonials or product-page outcome language.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

Who might find this useful?

CLYR offers a relatively clear way to compare a starter box with larger, dose-specific purchases. It suits a buyer willing to verify the exact package and resolve the refund contradiction before paying. It is not a flat-price plan at every dose, and its low starter figure should not stand in for the cost of later treatment.

For other purchasing structures, compare BiltRx and Cielo; the Corsica Health review provides another example of offer-access questions to check. Use the provider comparison to compare current disclosures and total commitments, not just introductory figures.